{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11458458", "DateCompleted": {"Year": "2001", "Month": "08", "Day": "09"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "67", "Issue": "4", "PubDate": {"Year": "2001", "Month": "Jun"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hpyericin, an active component of Hypericum perforatum.", "Pagination": {"StartPage": "364", "EndPage": "366", "MedlinePgn": "364-6"}, "Abstract": {"AbstractText": ["Hypericin, an active component of Hypericum perforatum, was evaluated for the regulation of interleukin-12 (IL-12) production in mouse macrophages. Hypericin significantly inhibited IL-12 production in lipopolysaccharide-activated macrophages in a dose-dependent manner (IC50 = 1.45 micrograms/ml). Furthermore, hypericin potently inhibited the activation of IL-12 gene promoter, suggesting that hypericin negatively regulated IL-12 production at the transcription level. These results may explain some known biological activities of hypericin including its anti-rheumatic effect."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Kang", "ForeName": "B Y", "Initials": "BY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "S W", "Initials": "SW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "T S", "Initials": "TS"}], "PublicationTypeList": ["Letter", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypericum"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Interleukin-2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred DBA"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Spleen"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "7", "Day": "19", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "8", "Day": "10", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "7", "Day": "19", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11458458", "10.1055/s-2001-14333"]}}], "PubmedBookArticle": []}